Ophthalmology 360?

A recent retrospective analysis examined the association between diabetes mellitus, neurotrophic keratopathy, and corneal ulcers. The study reviewed 136,992 health records from patients visiting a university outpatient clinic between January 2003 and February 2024. Read the complete article below ?? https://lnkd.in/ef5viPEB #NeurotrophicKeratitis #Diabetes #Cornea

"Successful enrollment in ophthalmic clinical trials hinges on strategic planning, robust partnerships, and meticulous execution. By leveraging data-driven insights, fostering strong relationships with clinical sites, and selecting experienced investigators, sponsors can enhance recruitment and retention, ensuring efficient trial completion." Read the complete article by Yesha Raval, MS, and Andrew D. Pucker, OD, PhD, FAAO Diplomate, FSLS, FBCLA ?? #Ophthalmology360 #ClinicalTrials #Ophthalmic #MedicalPractice #MacularDegeneration #Glaucoma

"Dry eye disease (DED) is a common condition encountered in clinical practice, yet its underlying pathophysiology remains complex and multifactorial. The ocular surface comprises various structures that work in harmony to maintain homeostasis. Disruption of any one of these components can lead to a breakdown in this balance, resulting in the vicious cycle of DED." Read the complete article written by Cory Lappin, OD, MS, FAAO, and Matthew Shulman, MD ?? https://lnkd.in/e7yKx9mx #DryEyeDisease #DryEye #OcularSurfaceDisease

Dextenza, a sustained-release dexamethasone insert, is an effective and convenient option for reducing postoperative inflammation in pediatric intraocular surgery, minimizing the need for frequent eye drops and improving treatment compliance, according to a paper presented at the 50th Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus. Read the complete article below ?? https://lnkd.in/e8vSZmxt #Cataracts #PediatricOphthalmology #CataractSurgery

Gene therapy is emerging as a promising treatment for genetic retinal disorders, with research demonstrating significant progress in animal models and early clinical trials, according to a presentation at the 50th Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus. Read more: https://lnkd.in/ezgyrpVp #EarlyOnsetCataracts #Cataracts #GeneTherapy #Genetics

Incredible day on the Hill yesterday with National Alliance for Eye and Vision Research (NAEVR) and Thomas V Johnson! We spoke about glaucoma from the perspective of the patient and clinician/researcher. Dr Johnson shared some of his incredible research on regrowing retinal ganglion cells. We also had the opportunity to meet with several Congressional offices to discuss the importance of continued funding for eye and vision research. Patients coupled with clinicians/researchers make magic happen. Separately we make a difference - together we create change!

In the latest episode of The Ophthalmic Project, Mark Dlugoss speaks with Sean Ianchulev MD MPH, of Iantrek about the company’s latest advancements in glaucoma care. In this clip, Dr. Ianchulev talks about how innovation can be daunting and uncertain, but how pushing forward and pivoting where needed helps move new ideas forward. Watch the complete video here: https://lnkd.in/eYtq-JNN #Innovation #IntravitrealInjections #Ophthalmic

Beautiful day here in D.C. ???? Excited to speak at the National Alliance for Eye and Vision Research (NAEVR) Glaucoma Congressional Briefing today with Thomas V Johnson! ??There is power when patients are coupled with researchers and clinicians to speak at events. Let’s do this!

The combination of topical ivermectin 1% and intense pulsed light (IPL) therapy significantly improves dry eye disease (DED) caused by demodex blepharitis, with notable reductions in blepharitis and meibomian gland dysfunction, according to a study. Read more: https://lnkd.in/eTaNzaku #DryEyeDisease #DemodexBlepharitis #MeibomianGlandDysfunction

During a session at the American Glaucoma Society Annual Meeting, titled “The Future Starts Now – What’s Next in the Supraciliary Space and Interventional Drug Delivery,” Analisa Arosemena, MD, of the Correct Vision Laser Institute, spoke about the use of travoprost intracameral implant (iDose?) for glaucoma management. Read more: https://lnkd.in/eg7WcbYv #Glaucoma #MIGS #GlaucomaSurgery